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www.sciencedirect.comEDITORIALPerspective: Lacrimal gland biopsy, is it important?Recent research work on the anatomy and histopathology of
the human lacrimal gland has led to our better understanding
of the lacrimal function and the diseases process that affects it.
Further understanding has come from realizing the age related
changes and the differences inferred by gender of the patient
(Obata, 2006).
The human lacrimal gland consists of the main lacrimal
gland and the accessory lacrimal gland. The main lacrimal
gland comprises palpebral and orbital lobes, which are contin-
uous with each other at the lateral edge of the aponeurosis of
levator palpebrae oris. The orbital lobe is approximately twice
as large as the palpebral lobe and lies in the lacrimal fossa on
the anterior lateral area of the orbit. The palpebral lobe lies be-
low the aponeurosis of levator palpebrae superioris and is in
contact with the superior and lateral fornix of conjunctiva.
Excretory ducts emerging from the palpebral and orbital lobes
open into the superior conjunctival fornix. The size of the main
lacrimal gland varies individually to some degree depending on
the age of the patient.
Changes in lacrimal gland in various diseases process are
common. An infectious process of the lacrimal gland may be
commonly due to viral etiology preceded by exposure to an in-
fected contact. Patient may present with signs of acute inﬂam-
mation in the form of pain, tenderness, and redness. Local
swelling over the eyelid may result in mechanical ptosis. The
conjunctiva may show severe chemosis and bloody tears. The
infection can be bilateral, with constitutional symptoms of
malaise, pre-auricular and cervical lymphadenopathy, and
can be associated with other organ involvement such as
parotitis. Compared to the viral etiology, bacterial or for-
eign-body-related lacrimal gland disease process may need
more intervention. Like many other diseases, the spectrum of
the lacrimal gland conditions, has expanded with the advances
in the immunohistochemistry, immunocytochemical phenotyp-
ing and molecular genetics. After excluding the above cited
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and relatively unpredictable course.
Because of the diversity of the lacrimal gland disorders, the
tendency to get its tissue diagnosis is encouraged for benign as
well as malignant tumors. In addition, lacrimal gland biopsy
may be beneﬁcial for the noninfectious inﬂammatory adenitis
that may be potentially the ﬁrst clinical presentation of a spe-
ciﬁc systemic disorder. Speciﬁc diseases with inﬂammatory pre-
sentation that may respond to corticosteroid are important for
diagnosis before treatment initiation. For example, sarcoidosis
(with non-caseating granuloma) can be a diagnostic dilemma
without a tissue diagnosis, although the treatment of choice
is also with corticosteroids which may not be good for fungal,
or tuberculous granulomas. These conditions can be best ver-
iﬁed only by biopsy.
The presence of uveitis may be more in favor of biopsy,
however it is absence should not preclude getting a tissue diag-
nosis for the knowledge of what one may be dealing with. The
literature on failed treatment of some cases of idiopathic orbi-
tal inﬂammation using corticosteroids indicates that an indi-
vidual case may not conform to the prior experience of the
physician or to that in published literature (Harris, 2006).
For example, a condition that is now a new entity is the disease
of the sclerosing lacrimal gland adenitis (Cheuk et al., 2007)
which was previously considered as part of the idiopathic orbi-
tal inﬂammation (IOI) category (Rootman, 2005). It is now a
known part of a systemic autoimmune disorder known as
IgG4-related sclerosing disease, of which the prototypic lesion
is lymphoplasmacytic sclerosing (autoimmune) pancreatitis
(Okazaki et al., 2006). Typically, sclerosing (autoimmune) pan-
creatitis manifests with tumor like picture of the pancreas that
can be thought of as carcinoma of the head of the pancreas
sometimes (Weber et al., 2003). IgG4-related sclerosing disease
is a known entity (Toomey et al., 2007). It often affects more
than one organ system, and usually showing good response
to corticosteroid therapy. The reported sites of involvement
are the pancreas (prototype), biliary tract, gall bladder, liver,
salivary gland, retroperitoneum, kidney, breast, lung, thyroid,
prostate, and lymph nodes. The spectrum of organs involved
by IgG4-related sclerosing disease includes the lacrimal gland.
The histological pattern is distinctive, in that marked ﬁbrosis is
present from the outset, not as the burned-out end-stage of a
cellular inﬁltrate of idiopathic IOI, which is a late manifesta-
tion of a localized condition of the orbit of unknown cause.
142 EditorialOf importance is the fact that the response to corticoste-
roids is not speciﬁc to benign inﬂammatory conditions, it
can occur with aggressive malignancies presenting with inﬂam-
matory signs. For example, lymphomas do respond to cortico-
steroids and it should be suspected in the bilateral cases of
lacrimal gland involvement. Further, lymphomas can present
concomitantly with rheumatological conditions, including
IgG4+ chronic sclerosing dacryoadenitis (Cheuk et al., 2008).
In conclusion, knowing the above stated facts, it is justiﬁ-
able to act in favor of lacrimal gland biopsy before initiating
any concrete treatment. It is appropriate to do all other diag-
nostic blood and radiological tests including PET scans, which
has become an established scanning tool in oncology in recent
years. PET scan is now entering the ﬁeld of clinical inﬂamma-
tory and infectious diseases because the inﬂammatory cells
take up large amount of glucose as a result of an increased
metabolic rate (Bleeker-Rovers et al., 2004). These tools are
valuable in showing the localization and the extent of the pro-
cess, but they are limited by non-speciﬁcity. Atypical lacrimal
gland process does need a tissue diagnosis.
Lacrimal gland biopsy from the accessible palpebral lobe le-
sions can be performed directly or after double upper lid ever-
sion technique for exposure of the superolateral fornix. As in
Sidle’s test, the use of undiluted ﬂouricine dye, for identiﬁca-
tion of the lacrimal duct oriﬁces as the tears egress out of it,
can help to preserve those ducts for the tear secretion in the
conjunctival sac. Anterolateral orbitotomy with or without
bone opening is the best way to get an adequate lacrimal gland
biopsy from the orbital lobe. One has to be sure to preserve the
lacrimal gland artery which can be utilized for chemosurgery
of conditions such as the lacrimal gland adenoid cystic carci-
noma (Erdogmus and Govsa, 2005). The advances in the che-
mo-surgical techniques have helped in changing the
therapeutic modalities to less aggressive surgical excisions,
more focused chemotherapeutic drug delivery to the tumor
with less systemic doses and toxicity and with better survival
rate of the patients (Gupta et al., 2006).References
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